- DocumentAn Introduction to Kinases and Kinase Inhibitorsuploaded byBiotech Investors' Database
- DocumentLa Transformation d'Oncodesign ... à Paris-Saclayuploaded byBiotech Investors' Database
- DocumentOncodesign in Paris-Saclayuploaded byBiotech Investors' Database
- DocumentThe Big Picture For Genfit_NASH+diabetes+CVDuploaded byBiotech Investors' Database
- DocumentNo Doubt Genfit's Elafibranor cures Nashuploaded byBiotech Investors' Database
- DocumentNew Genfit Data Challenge Placebo-Positive and Elafibranor-Negative Biopsy Interpretationsuploaded byBiotech Investors' Database
- DocumentL'Action Du GFT505 Sur Les Récepteurs Nucléaires PPARuploaded byBiotech Investors' Database
- DocumentCellectis Demonstrates Potential of Allogenic CAR-T Technologyuploaded byBiotech Investors' Database
- DocumentThe Paradox of Obeticholic Acid for the Treatment of NASHuploaded byBiotech Investors' Database
- DocumentGFT505, Genfit's PPAR Agonist for the Treatment of NASHuploaded byBiotech Investors' Database